荃信生物该不该打新？港股带B的胜率如此之高？_老虎社区_美港股上老虎

荃信生物该不该打新？港股带B的胜率如此之高？

小斯新报道
03-12

$荃信生物－Ｂ(02509)$ 该不该打新？

从过去一年半的为盈利生物医药公司的表现来看，打新赚钱的可能远大于不赚钱。

荃信生物有“港股自免第一股”之称，市值约为43.97亿港元至44.86亿港元，预计募资的比例也不足5%，流通盘依然非常小。

# 百度涨超5%！你看好“中丐”变“中概”吗？

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

Lydia758
·03-12
阅
回复
点赞
举报
年年有于姨
·03-12
已阅
回复
点赞
举报

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":283439965155424,"tweetId":"283439965155424","gmtCreate":1710225237059,"gmtModify":1710225328204,"author":{"id":279327367386116,"authorId":279327367386116,"authorIdStr":"279327367386116","name":"小斯新报道","avatar":"https://static.tigerbbs.com/7ae5ca6ae332a96f7211e19a07d9c529","vip":2,"userType":2,"introduction":"美股市场达人&IPO小司机","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"starInvestorFlag":false},"themes":[{"themeId":"42eb707419794da0a1706b922f2c1037","categoryId":"d316d8bd4a714fab9ea15fd7157c45e7","name":"百度涨超5%！你看好“中丐”变“中概”吗？","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":42eb707419794da0a1706b922f2c1037}&rnconfig={\"headerBarHidden\": true}","description":"热门中概股表现不俗，理想汽车涨超7%，百度、小鹏汽车涨超3%，哔哩哔哩、阿里\n巴巴、爱奇艺涨超1%。【你觉得这次中概能否上车？是短暂反弹，还是能持续连涨呢？】","image":"https://static.tigerbbs.com/10340a991f3653d63b92a460cd394387"}],"images":[{"img":"https://static.tigerbbs.com/623f72ef34302314c105953d0a29305d","width":"1359","height":"496"}],"coverImages":[{"img":"https://static.tigerbbs.com/623f72ef34302314c105953d0a29305d","width":"1359","height":"496"}],"title":"荃信生物该不该打新？港股带B的胜率如此之高？","html":"<html><head></head><body> <a data-mention-id=\"02509\" class=\"teditor-mention\" data-mention-name=\"荃信生物－Ｂ\" href=\"https://laohu8.com/S/02509\">$荃信生物－Ｂ(02509)$</a> 该不该打新？从过去一年半的为盈利生物医药公司的表现来看，打新赚钱的可能远大于不赚钱。荃信生物有“港股自免第一股”之称，市值约为43.97亿港元至44.86亿港元，预计募资的比例也不足5%，流通盘依然非常小。<img src=\"https://static.tigerbbs.com/623f72ef34302314c105953d0a29305d\" tg-width=\"1359\" tg-height=\"496\"></body></html>","htmlText":"<html><head></head><body> <a data-mention-id=\"02509\" class=\"teditor-mention\" data-mention-name=\"荃信生物－Ｂ\" href=\"https://laohu8.com/S/02509\">$荃信生物－Ｂ(02509)$</a> 该不该打新？从过去一年半的为盈利生物医药公司的表现来看，打新赚钱的可能远大于不赚钱。荃信生物有“港股自免第一股”之称，市值约为43.97亿港元至44.86亿港元，预计募资的比例也不足5%，流通盘依然非常小。<img src=\"https://static.tigerbbs.com/623f72ef34302314c105953d0a29305d\" tg-width=\"1359\" tg-height=\"496\"></body></html>","text":"$荃信生物－Ｂ(02509)$ 该不该打新？ 从过去一年半的为盈利生物医药公司的表现来看，打新赚钱的可能远大于不赚钱。 荃信生物有“港股自免第一股”之称，市值约为43.97亿港元至44.86亿港元，预计募资的比例也不足5%，流通盘依然非常小。","highlighted":1,"essential":1,"paper":2,"likeSize":6,"commentSize":2,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/283439965155424","repostId":0,"isVote":1,"tweetType":1,"viewCount":12144,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["02509"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":true,"length":204,"xxTargetLangEnum":"ZH_CN"},"commentList":[{"id":283453064048960,"gmtCreate":1710230873126,"gmtModify":1710230876643,"authorId":3552609846285590,"author":{"id":3552609846285590,"authorId":3552609846285590,"name":"Lydia758","avatar":"https://static.tigerbbs.com/28fe40b632359d10a879ebb9a9eef57b","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":283439965155424,"type":1,"supId":0,"prevId":0,"content":"阅","text":"阅","html":"阅","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"invalid","coins":0,"score":0},{"id":283431468728440,"gmtCreate":1710225581131,"gmtModify":1710225584798,"authorId":4125470478750332,"author":{"id":4125470478750332,"authorId":4125470478750332,"name":"年年有于姨","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":283439965155424,"type":1,"supId":0,"prevId":0,"content":"已阅","text":"已阅","html":"已阅","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"invalid","coins":0,"score":0}],"hasMoreComment":true,"orderType":2}

荃信生物该不该打新？港股带B的胜率如此之高？

评论（2）

热议股票